Daiichi Sankyo News
Most Popular Daiichi Sankyo Story
Daiichi Sankyo acquires Ranbaxy in $4.6B deal
Ranbaxy's drive to become a research-based drug developer and major manufacturer has led it straight into the... Read more...
Latest Headlines
- November 13, 2009
- July 13, 2009
- February 24, 2009
- February 4, 2009
- January 14, 2009
- November 10, 2008
- October 17, 2008
- September 29, 2008
- July 23, 2008
- June 24, 2008
- June 13, 2008
- June 11, 2008
- May 21, 2008
- February 22, 2008
- January 4, 2008
- October 25, 2007
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact
